BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Abdalla MMI. Insulin resistance as the molecular link between diabetes and Alzheimer's disease. World J Diabetes 2024; 15(7): 1430-1447 [PMID: 39099819 DOI: 10.4239/wjd.v15.i7.1430]
URL: https://www.wjgnet.com/1007-9327/full/v15/i7/1430.htm
Number Citing Articles
1
Ju Wu, Jin Li, Xiaolan Qin, Weiping Chen. Association between diabetes mellitus and risk of Alzheimer’s disease: a meta-analysis and systematic review. Frontiers in Endocrinology 2026; 17 doi: 10.3389/fendo.2026.1736410
2
Odete Mendes. Diabetes and Neurodegeneration. 2026;  doi: 10.1016/B978-0-443-33355-2.00003-7
3
Fatemeh Nezamzadeh, Azin Masroor, Aylin Esmailkhani, Abed Zahedi Bialvaei. Exploring the complex interplay: insulin resistance and gut microbiome dysbiosis in multiple sclerosis. Neuroscience 2025; 582 doi: 10.1016/j.neuroscience.2025.07.024
4
Kenneth Maiese. Circadian Rhythm, Clock Genes, and Stroke. Current Neurovascular Research 2025; 21(4) doi: 10.2174/1567202622999241028121817
5
Alexandra M. Johnstone, Emiliano Albanese, Daniel R. Crabtree, Boushra Dalile, Stefanie Grabrucker, Jenna M. Gregory, Giuseppe Grosso, Adrian Holliday, Catherine Hughes, Catherine Itsiopoulos, John Mamo, Claire McEvoy, Phyo Kyaw Myint, Leticia Radin Pereira, David Vauzour, Mario Siervo. Consensus statement on exploring the Nexus between nutrition, brain health and dementia prevention. Nutrition & Metabolism 2025; 22(1) doi: 10.1186/s12986-025-00981-6
6
Rasoul Ebrahimi, Zahra Golzari, Mahsa Heidari-Foroozan, Abolfazl Khosravi, Samin Ghaheri Sharghi, Mobina Saleh, Shakiba Salarvandian, Khadijeh Esmaeilpour. Impaired Synaptic Plasticity Mechanisms in Alzheimer’s Disease. Metabolic Brain Disease 2025; 40(7) doi: 10.1007/s11011-025-01712-9
7
Kiran Marathe, Dhruv Sanjay Gupta, Kalyani Barve, Dhananjay Bodas. A critical appraisal of drug transport across the blood-brain barrier: Evaluation using new-age microfluidic technique. Brain Research Bulletin 2026; 234 doi: 10.1016/j.brainresbull.2025.111662
8
Hsuan-Yu Huang, Yu-Yin Huang, Chia-Lin Wu, Wei-Chien Huang, Chih-Ho Lai. Smog, sugar, and synapses: Unraveling the PM2.5-insulin resistance-Alzheimer’s disease axis. Redox Biology 2026; 90 doi: 10.1016/j.redox.2026.104031
9
Rahul Kumar, Ankita Devi, Anamika Sharma, Karadagatla Suman, Shovit Ranjan. Neurobiology of Type 2 Diabetes. 2026;  doi: 10.1016/B978-0-443-32848-0.00022-4
10
Muskan Bhatia, Sidharth P. Mishra, Raghvendra K. Mishra, Shalini Jain, Hariom Yadav, Rajesh S. Tomar. Gut Microbiota and Brain Aging: Identifying Keystone Biomarkers for Cognitive Health. Biomedicines 2026; 14(9) doi: 10.3390/biomedicines14091975
11
Kenneth Maiese. Diabetes mellitus and glymphatic dysfunction: Roles for oxidative stress, mitochondria, circadian rhythm, artificial intelligence, and imaging. World Journal of Diabetes 2025; 16(1): 98948 doi: 10.4239/wjd.v16.i1.98948
12
Md Abubakar, Aditi Giri, Falguni Goel, Manshad Khan, Janmejay Gupta, Daksh Kumar, Monika Kaushik, Sachchida Nand Rai, Nitesh Kumar. Diabetes, Alzheimer's Disease Risk Factors, and the Cafeteria Diet: A Comprehensive Review. Current Neuropharmacology 2026; 24(4) doi: 10.2174/011570159X384737250626094315
13
Qi Qiao, Yuriko Katsumata, Hsin‐Yu Lai, Kevin Z. Lin, Steven A. Claas, Mariano I. Gabitto, Josh M. Morganti, Peter T. Nelson, Shubhabrata Mukherjee, David W. Fardo. Distinct single‐nucleus RNA‐seq changes among non‐neuronal cells in ADNC, LATE‐NC, and mixed pathologies. Alzheimer's & Dementia 2026; 22(9) doi: 10.1002/alz.71810
14
Mona Mohamed Ibrahim Abdalla. Gut-liver axis in diabetes: Mechanisms and therapeutic opportunities. World Journal of Gastroenterology 2025; 31(29): 109090 doi: 10.3748/wjg.v31.i29.109090
15
John Cheung-Yuen Chan. Alzheimer's disease model explains Alzheimer’s disease incidences. Journal of Alzheimer's Disease Reports 2025; 9 doi: 10.1177/25424823251395616
16
Gunjan Adwani, Awanish Kumar. Diabetes and Alzheimer's Disease. 2026;  doi: 10.1016/B978-0-443-40559-4.00007-6
17
Giulia Frank, Paola Gualtieri, Rossella Cianci, Mario Caldarelli, Roselisa Palma, Gemma Lou De Santis, Chiara Porfilio, Francesco Nicoletti, Giulia Bigioni, Laura Di Renzo. Body Composition and Alzheimer’s Disease: A Holistic Review. International Journal of Molecular Sciences 2024; 25(17) doi: 10.3390/ijms25179573
18
Ahmad Raza, Shafaq Saleem, Samar Imran, Sarah Rahman, Muhammad Haroon, Azeen Razzaq, Ahmad Hussain, Javed Iqbal, Brijesh Sathian. From metabolic dysregulation to neurodegenerative pathology: the role of hyperglycemia, oxidative stress, and blood-brain barrier breakdown in T2D-driven Alzheimer’s disease. Metabolic Brain Disease 2025; 40(7) doi: 10.1007/s11011-025-01700-z
19
Kenneth Maiese. Anxiety and Depression: Triggers for Cognitive Loss, Alzheimer's Disease, and Neurodegeneration. Current Neurovascular Research 2025; 22(1) doi: 10.2174/0115672026423887250627095817
20
Riddhi Upadhyay, Sneha Santhosh, R. Malathi, P. Saravana Kumari, S. Vijayanand, Murugan Sevanan. Brain Energy Metabolism in Alzheimers Disease - Part A. International Review of Neurobiology 2026; 186 doi: 10.1016/bs.irn.2026.01.010
21
Rajalakshmi Ramashetty, Rimshia Naaz, Ramya C M, SubbaRao V. Madhunapantula, Chinnappa A. Uthaiah. Amyloid Beta Biomarkers and Their Association with Cognitive Impairment Across Vitamin D Strata: A Cross-Sectional Study in an Older Adult South Indian Population. Nutrients 2026; 18(18) doi: 10.3390/nu18182942
22
Suman Manandhar, Prasada Chowdari Gurram, Anusha Govindula, Shama Prasada Kabekkodu, K Sreedhara Ranganath Pai. Voglibose Attenuates Amyloid Beta–Induced Memory Deficits in a Rodent Model: A Potential Alzheimer’s Therapy via Wnt Signaling Modulation. Molecular Neurobiology 2025; 62(9) doi: 10.1007/s12035-025-05047-5
23
Shuangshuang Yang, Lili Cui, Jinxin Zhang, Ying Yang, Junhao Huo, Yuyan Ding, Jingni Zhang, Shulan He, Jiangping Li, Qian Wu. Association of triglyceride-glucose index (TyG) and a body shape index (ABSI) with cognitive decline and dementia risk. PLOS One 2026; 21(7) doi: 10.1371/journal.pone.0354418
24
Kenneth Maiese. Osteoarthritis and dementia: contrasting disorders driven by mutual pathways of autophagy, mTOR, GLP-1, AMPK, Wnt, and WISP1. Expert Review of Clinical Pharmacology 2026; 19(5) doi: 10.1080/17512433.2026.2671269
25
Dhriti P. Shah, Amee Krishnakumar. Diabetes and Alzheimer's Disease. 2026;  doi: 10.1016/B978-0-443-40559-4.00014-3
26
Sandesh Kumar Pattanaik, Prajapati Manisha Anil, Sudipta Jena, Diptirani Rath. Interlinking diabetes and Alzheimer's disease: A pathway through medicinal plant-based treatments. Journal of Ethnopharmacology 2025; 351 doi: 10.1016/j.jep.2025.120092
27
Junying Song, Yong Yuan, Mao Wang, Junlin Li, Rui Ding, Yaquan Jia, Zichuang Wang, Zhishen Xie, Zhonghua Li, Zhenqiang Zhang. Liuwei Dihuang pills attenuates cognitive dysfunction in APP/PS1 mice through restoring mitochondrial homeostasis and activating the IRS/AKT/GSK3β insulin signaling pathway. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1873606
28
Ankita Sharma, Aman Jyoti, Prasad Rasane, Jyoti Singh. Protecting vascular health: the role of flavonoids during pregnancy complications in mitigating the risk of vascular dementia later in life. Inflammopharmacology 2025; 33(6) doi: 10.1007/s10787-025-01788-w
29
Majid Tozihi, Alireza Nourazarian, Hadi Yousefi, Gholamreza Dehghan. Methylglyoxal-induced neuronal dysfunction: Linking diabetes to Alzheimer's disease through cytoskeletal disruption. European Journal of Pharmacology 2025; 998 doi: 10.1016/j.ejphar.2025.177526
30
Rasha E. Mostafa, Gihan F. Asaad. Bridging the gaps in alzheimer’s disease: a comprehensive review of current and emerging therapies. Inflammopharmacology 2026; 34(4) doi: 10.1007/s10787-026-02151-3
31
Kenneth Maiese. Oxidative stress, aging, metabolism, SIRT1, and the gut microbiota: the neurocardiac basis of cognitive loss. Medical Gas Research 2026;  doi: 10.4103/mgr.MEDGASRES-D-26-00073
32
Laura Maria De Plano, Luigi Chiricosta, Simone D’Angiolini, Alessandra Saitta, Alessandra Trainito, Serena Silvestro, Sabrina Conoci, Salvatore Oddo, Antonella Caccamo. A phage displaying an Aβ-interacting peptide mitigates neurotoxicity and prevents Aβ-driven gene expression changes. Frontiers in Molecular Neuroscience 2025; 18 doi: 10.3389/fnmol.2025.1716626
33
Zhang Heng, Yamato Yotsuya, Tomoki Omachi, Yasushi Hasegawa. Nacre extract improves insulin resistance and cognitive functions in diabetic mice. Asian Pacific Journal of Tropical Biomedicine 2025; 15(11) doi: 10.4103/apjtb.apjtb_458_25
34
Himanshu Vishwakarma, Abhishek Chauhan, Loveleen Kaur, Ankit Awasthi. Nanotechnology-enabled targeting strategies for neurodegenerative disorders: role of functionalized nanoparticles. Journal of Pharmacy and Pharmacology 2026; 78(6) doi: 10.1093/jpp/rgag060
35
Shivani Chib, Bhaskar Jyoti Dutta, Rishabh Chalotra, Md Abubakar, Puneet Kumar, Thakur Gurjeet Singh, Randhir Singh. Role of Flavonoids in Mitigating the Pathological Complexities and Treatment Hurdles in Alzheimer's Disease. Phytotherapy Research 2025; 39(2) doi: 10.1002/ptr.8406
36
Bo Wang, Yuping Shao, Rongxiang Liang. Exercise Suppresses Insulin Resistance: A Potential Mechanism for Improving the Interaction Between Type 2 Diabetes and Alzheimer’s Disease. Journal of Integrative Neuroscience 2026; 25(1) doi: 10.31083/JIN44389
37
Rosalinda Di Gerlando, Francesca Dragoni, Evelyne Minucchi, Maria Garofalo, Giulia Perini, Alfredo Costa, Antonio Pisani, Carlo Morasso, Matteo Cotta Ramusino, Stella Gagliardi. Plasma-Derived miRNAs as Fluid Biomarkers to Differentiate Alzheimer’s and Frontotemporal Dementia. Current Issues in Molecular Biology 2026; 48(6) doi: 10.3390/cimb48060633
38
Ana Knezovic, Antonia Krsnik, Jan Homolak, Ana Babic Perhoc, Ana Deskin, Davor Virag, Melita Salkovic-Petrisic, Jelena Osmanovic Barilar. From systems to cells: Metabolic mechanisms underlying risk divergence in Alzheimer’s disease and amyotrophic lateral sclerosis. Neuroscience & Biobehavioral Reviews 2026; 191 doi: 10.1016/j.neubiorev.2026.106982
39
Qiwen Cheng, Jennifer Nolz, Timothy Karr, Nicole Dorn, Benjamin Readhead, Rosa Krajmalnik‐Brown, Diego Mastroeni. Gut proteome and microbiome alterations: Analysis of transverse colon samples from pathologically confirmed Alzheimer's disease patients. Alzheimer's & Dementia 2026; 22(1) doi: 10.1002/alz.71021
40
Kenneth Maiese. Agitation, Alzheimer’s disease, and autophagy: mechanistic insights into aging pathways, gut microbiome, and artificial intelligence. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1846280
41
Faisal Alzenaidi, Osama Aldoweesh, Salman Alghofaili, Abdulaziz Fadel, Razan Ali Awad Lasloom, Dhay Alharbi, Faris Almalki, Atheer Ahmad Alkhairi, Maram Alharbi, Norah Ahmed Alhamdan, Ahmed Y. Azzam. Selective serotonin reuptake inhibitors and glucose metabolism in Alzheimer's disease and related dementias: A systematic review and meta-analysis of brain metabolic and adverse event data. Metabolism Open 2025; 27 doi: 10.1016/j.metop.2025.100389
42
Archana Mishra, Debasish Hota. Diabetes and Neurodegeneration. 2026;  doi: 10.1016/B978-0-443-33355-2.00008-6
43
Maria Teresa Venuti, Federico Brandalise, Mattia Cappelletti, Attilio F. Speciani, Michela C. Speciani, Erica Cecilia Priori, Francesca Giammello, Elisa Roda, Paola Rossi, Daniela Ratto. Peripheral metabolic dysfunction is associated with cognitive frailty in a mouse model of type 2 diabetes. Metabolic Brain Disease 2026; 41(1) doi: 10.1007/s11011-026-01956-z
44
Mengfan Xu, Jia Wang, Yuqing She, Junbo He, Mei Yu, Zhenwen Zhang, Penghua Fang. The role of galanin/GALR2 signaling in the link between type 2 diabetes and Alzheimer's disease. Neuropeptides 2026; 116 doi: 10.1016/j.npep.2026.102586
45
Tanya Gupta, Shivam Kumar, Thakur Gurjeet Singh, Randhir Singh. The metabolic roots of memory loss: interlinking the Diabetes-Alzheimer’s hypothesis. Metabolic Brain Disease 2026; 41(1) doi: 10.1007/s11011-026-01824-w
46
Abhishek Mishra, Bhabani Sankar Satapathy, Pratap Kumar Sahu. Solid lipid nanoparticles enhance piracetam’s neuroprotective action in streptozotocin-induced cognitive dysfunction. Discover Nano 2026; 21(1) doi: 10.1186/s11671-026-04528-3
47
Asha Abraham, Vijayalakshmi Gangadhara, Pallavi Baliga. Diabetes and Alzheimer's Disease. 2026;  doi: 10.1016/B978-0-443-40559-4.00008-8
48
Kyle W. Cuklanz, Abigail Stein, Virginie-Anne Chouinard, Dost Ongur, Fei Du. Redox therapy for neuropsychiatric disorders: Molecular mechanisms and biomarker development. Science Advances 2026; 12(8) doi: 10.1126/sciadv.aea9014
49
Kenneth Maiese. Wnt Signaling, Musculoskeletal Disease, and the Onset of Dementia and Alzheimer's Disease. Current Neurovascular Research 2025; 21(5) doi: 10.2174/1567202622999241211154331
50
Anujit Saha, Wen Shi, Mohamad N. Elsharydah, Jeff Schaffert, Jack Kaufman, Jennine Leary, Alison Jin, Jaime P. Almandoz, Hanzhang Lu, Binu P. Thomas. Blood-brain barrier water permeability is elevated in type 2 diabetes and obesity: associations with cognitive function and metabolic markers. Fluids and Barriers of the CNS 2026; 23(1) doi: 10.1186/s12987-026-00843-0
51
Huimin Cao, Yuying Zhao, Ziyi Chen, Xiaoya Zou, Xinyi Du, Li Yi, Yu Ai, Hongzhou Zuo, Oumei Cheng, Julia Gallagher, Alice S. Chen-Plotkin, Nabila Dahodwala, James F. Morley, Andrew D. Siderowf, Allison W. Willis, Daniel Weintraub, Eugenia Mamikonyan, Sharon X. Xie, Caroline Gochanour, Chelsea Caspell-Garcia, Christopher S. Coffey, Roseanne D. Dobkin, Dag Aarsland, Roy N. Alcalay, Matthew J. Barrett, Lana M. Chahine, Jamie L. Eberling, Alberto J. Espay, James B. Leverenz, Irene Litvan, Irene H. Richard, Liana S. Rosenthal, Tatyana Simuni, Michele K. York. Triglyceride-glucose index predicts cognitive decline and striatal dopamine deficiency in Parkinson disease in two cohorts. npj Parkinson's Disease 2025; 11(1) doi: 10.1038/s41531-025-01100-1
52
Monika Pliszka, Leszek Szablewski. Insulin Signaling in Alzheimer’s Disease: Association with Brain Insulin Resistance. International Journal of Molecular Sciences 2026; 27(3) doi: 10.3390/ijms27031222
53
Muhammad Sohail Khan, Ashfaq Ahmad, Somayyeh Nasiripour, Jean C. Bopassa. Type 2 Diabetes and Alzheimer’s Disease: Molecular Mechanisms and Therapeutic Insights with a Focus on Anthocyanin. Journal of Dementia and Alzheimer's Disease 2026; 3(1) doi: 10.3390/jdad3010005
54
Ramesh Kordi, Ted J. Andrews, Mark D. Hicar. Infections, genetics, and Alzheimer's disease: Exploring the pathogenic factors for innovative therapies. Virology 2025; 607 doi: 10.1016/j.virol.2025.110523
55
Kenneth Maiese. Cannabis and Cannabidiol: Pioneering Treatment for the Nervous System with Alzheimer's Disease and Peripheral Organ Involvement with Nonalcoholic Fatty Liver Disease (NAFLD). Current Neurovascular Research 2025; 22(2) doi: 10.2174/0115672026446790250918074353
56
N.M. Zherdova, O.O. Kopchak, I.M. Todurov, O.V. Perekhrestenko, K.O. Hrynevych, O.A. Stepura, O.S. Orlyk. Assessment of psychoemotional state and cognitive functions in patients with metabolic syndrome. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) 2026; 22(4) doi: 10.22141/2224-0721.22.4.2026.1731
57
Arantxa Rodriguez-Casado, Mª Isabel Alvarez, Jose-Joaquin Merino, Adolfo Toledano-Díaz, Adolfo Toledano. Relationship between Alzheimer's Disease and Type 2 Diabetes: Critical Review On Cellular and Molecular Common Pathogenic Mechanisms. Current Alzheimer Research 2025; 22(2) doi: 10.2174/0115672050375461250325074826
58
Reham Hassan Mekky, Mareena M. Thabet, Omayma El-Gindi, Mohamed Adel Said, Safwat A. Ahmed, Reda F. A. Abdelhameed. Comparative phytochemical and biological evaluation of Egyptian Swinglea glutinosa stems and leaves. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-00427-2
59
Ayse Nur Hazar-Yavuz, Humeysa Kiyak-Kirmaci, Hanife Serife Aktas, Ozlem Tugce Cilingir-Kaya, Levent Kabasakal, Hatice Kubra Elcioglu. Effects of thymoquinone on cognitive functions and kynurenine metabolites induced in rats by streptozotocin/nicotinamide. European Journal of Pharmacology 2026; 1011 doi: 10.1016/j.ejphar.2025.178383
60
Kannayiram Alagiakrishnan, Tyler Halverson. Role of Peripheral and Central Insulin Resistance in Neuropsychiatric Disorders. Journal of Clinical Medicine 2024; 13(21) doi: 10.3390/jcm13216607
61
Sultan Mohammed Alanazi, Hayder M. Al-Kuraishy, Ahmed M. Abdelaziz, Eidah M. Alasmari, Fatimah M. Yousef, Ahmed A. Mohamed, Mohamed M. Salama, Gaber El-Saber Batiha. Berberine as a multi-hallmark modulator of aging: From AMPK and mitophagy to inflammaging and the SASP. Fitoterapia 2026; 195 doi: 10.1016/j.fitote.2026.107497
62
Tara J. Jewell, Michelle Minehan, Jackson Williams, Nathan M. D’Cunha. Precision Nutrition for Dementia: Exploring the Potential in Mitigating Dementia Progression. Journal of Dementia and Alzheimer's Disease 2025; 2(3) doi: 10.3390/jdad2030028
63
Anery Shah, Gaurav Doshi. Insulin resistance and SIRT1 dysregulation in neurodegenerative diseases. Ageing Research Reviews 2026; 117 doi: 10.1016/j.arr.2026.103072
64
Like Yang, Yutao Wang, Ruofei Han, Kundi Lv, Xue Pang, Kuiquan Song, Yanxia Hu. Comparative associations of the TyG index and METS-IR with arterial stiffness in women: a cross-sectional analysis by menopausal status. Frontiers in Endocrinology 2026; 17 doi: 10.3389/fendo.2026.1902406
65
Rakesh Meher, Roja Sahu, Santosh Kumar Ranajit, Trupti Rekha Swain, Biswajeet Acharya, Jack Feehan, Prafulla Kumar Sahu, Vasso Apostolopoulos. Pathomechanisms, genetic insights, and therapeutics in diabetes-associated dementia. Journal of Endocrinology 2025; 267(2) doi: 10.1530/JOE-25-0016
66
Pushpa Yadav, Priya Singh. Diabetes and Alzheimer's Disease. 2026;  doi: 10.1016/B978-0-443-40559-4.00004-0
67
Kenneth Maiese. Biological gases, oxidative stress, artificial intelligence, and machine learning for neurodegeneration and metabolic disorders. Medical Gas Research 2025; 15(1) doi: 10.4103/mgr.MEDGASRES-D-24-00059
68
Eunji Lee, Jiyun Hwang, Dong Woo Kim, Byung Yoon Choi, Hee-Joon Bae, Seung Hyun Won, Young Ho Park, SangYun Kim. Association between high carbohydrate to dietary fiber ratio and risk of dementia in older adults: analysis from the UK biobank. BMC Neurology 2025; 26(1) doi: 10.1186/s12883-025-04583-w
69
Tanisha Tabassum Sayka Khan, Chun Yuen Jerry Wong, Zara Sheikh, Ali Fathi, Simin Maleknia, Farshad Oveissi, Terence Abrams, Will Knox, Julia van der Hoven, Abi Antonito, Michael Murray, Maree Svolos, Julie Suman, Ole Tietz, Hui Xin Ong, Daniela Traini. Repurposing insulin for Alzheimer’s disease treatment: intranasal delivery of a thermoresponsive nanocarrier-based insulin formulation to the brain. Drug Delivery and Translational Research 2026;  doi: 10.1007/s13346-026-02146-1
70
Daniela Dimitrova, Gabriela Kehayova, Simeonka Dimitrova, Stela Dragomanova. Marine-Derived Natural Substances with Anticholinesterase Activity. Marine Drugs 2025; 23(11) doi: 10.3390/md23110439
71
Atiyeh Kolouei, Mohammad Barati. Molecular interactions of diabetes medications with alzheimer’s related targets by molecular docking. Journal of Diabetes & Metabolic Disorders 2025; 24(2) doi: 10.1007/s40200-025-01747-w
72
Chieh Chen, Da-Ming Liao. A literature review on the relationship between diabetes and dementia. Tungs' Medical Journal 2026;  doi: 10.4103/ETMJ.ETMJ-D-25-00032
73
Mona Mohamed Ibrahim Abdalla. Advancing diabetes management: Exploring pancreatic beta-cell restoration’s potential and challenges. World Journal of Gastroenterology 2024; 30(40): 4339-4353 doi: 10.3748/wjg.v30.i40.4339
74
Kai Chen, Yiqing Nong, Ying Liu, Ziming Ye. Insulin Resistance Across Cerebrovascular and Related Disorders: Mechanisms, Measurement, Genetics, and Clinical Implications. Neuropsychiatric Disease and Treatment 2026;  doi: 10.2147/NDT.S575306
75
Parinaz Hajeforoosh, Akbar Hajizadeh Moghaddam, Sedigheh Khanjani Jelodar. Insulin resistance as a driver of neuroinflammation and oxidative stress in Alzheimer's disease: Mechanistic links and therapeutic approaches. Biomedicine & Pharmacotherapy 2026; 202 doi: 10.1016/j.biopha.2026.119760
76
Kenneth Maiese. . International Review of Neurobiology 2026; 190 doi: 10.1016/bs.irn.2026.08.015